Clinical trial

Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension

NCT00686803

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-04-01

PhasePHASE2

Study timeline

Study start (unknown)2008-04-01Date precision: month

Registry last updated2013-07-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

PL3994DRUG

PlaceboDRUG

Sponsors & collaborators

Palatin Technologies, Inclead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00686803 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.